Publication:
Rational design of a series of novel amphipathic cell-penetrating peptides

dc.contributor.authorJakob Regbergen_US
dc.contributor.authorArtita Srimaneeen_US
dc.contributor.authorMikael Erlandssonen_US
dc.contributor.authorRannar Sillarden_US
dc.contributor.authorDimitar A. Dobcheven_US
dc.contributor.authorMati Karelsonen_US
dc.contributor.authorÜlo Langelen_US
dc.contributor.otherStockholms universiteten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Tartuen_US
dc.contributor.otherTallinn University of Technologyen_US
dc.date.accessioned2018-11-09T03:10:22Z
dc.date.available2018-11-09T03:10:22Z
dc.date.issued2014-04-10en_US
dc.description.abstractA series of novel, amphipathic cell-penetrating peptides was developed based on a combination of the model amphipathic peptide sequence and modifications based on the strategies developed for PepFect and NickFect peptides. The aim was to study the role of amphipathicity for peptide uptake and to investigate if the modifications developed for PepFect peptides could be used to improve the uptake of another class of cell-penetrating peptides. The peptides were synthesized by solid phase peptide synthesis and characterized by circular dichroism spectroscopy. Non-covalent peptide-plasmid complexes were formed by co-incubation of the peptides and plasmids in water solution. The complexes were characterized by dynamic light scattering and cellular uptake of the complexes was studied in a luciferase-based plasmid transfection assay. A quantitative structure-activity relationship (QSAR) model of cellular uptake was developed using descriptors including hydrogen bonding, peptide charge and positions of nitrogen atoms. The peptides were found to be non-toxic and could efficiently transfect cells with plasmid DNA. Cellular uptake data was correlated to QSAR predictions and the predicted biological effects obtained from the model correlated well with experimental data. The QSAR model could improve the understanding of structural requirements for cell penetration, or could potentially be used to predict more efficient cell-penetrating peptides. © 2014 Elsevier B.V.en_US
dc.identifier.citationInternational Journal of Pharmaceutics. Vol.464, No.1-2 (2014), 111-116en_US
dc.identifier.doi10.1016/j.ijpharm.2014.01.018en_US
dc.identifier.issn18733476en_US
dc.identifier.issn03785173en_US
dc.identifier.other2-s2.0-84896736402en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34904
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84896736402&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleRational design of a series of novel amphipathic cell-penetrating peptidesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84896736402&origin=inwarden_US

Files

Collections